about
Mechanistic differences in RNA-dependent DNA polymerization and fidelity between murine leukemia virus and HIV-1 reverse transcriptasesPolycitone A, a novel and potent general inhibitor of retroviral reverse transcriptases and cellular DNA polymerasesAnalysis of nonnucleoside drug-resistant variants of human immunodeficiency virus type 1 reverse transcriptaseOltipraz, an inhibitor of human immunodeficiency virus type 1 replicationSpecific inhibition of the reverse transcriptase of human immunodeficiency virus type 1 and the chimeric enzymes of human immunodeficiency virus type 1 and type 2 by nonnucleoside inhibitorsSynergistic anti-human immunodeficiency virus type 1 effect of hydroxamate compounds with 2',3'-dideoxyinosine in infected resting human lymphocytesStructure-based design of novel dihydroalkoxybenzyloxopyrimidine derivatives as potent nonnucleoside inhibitors of the human immunodeficiency virus reverse transcriptaseUnique intracellular activation of the potent anti-human immunodeficiency virus agent 1592U89Mode of inhibition of HIV reverse transcriptase by 2-hexaprenylhydroquinone, a novel general inhibitor of RNA-and DNA-directed DNA polymerasesImpaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitorsIncreased activation of the combination of 3'-azido-3'-deoxythymidine and 2'-deoxy-3'-thiacytidine in the presence of hydroxyureaMutagenesis of key residues identifies the connection subdomain of HIV-1 reverse transcriptase as the site of inhibition by heme.The connection domain is implicated in metalloporphyrin binding and inhibition of HIV reverse transcriptase.A novel small molecular weight compound with a carbazole structure that demonstrates potent human immunodeficiency virus type-1 integrase inhibitory activity.Host sequence motifs shared by HIV predict response to antiretroviral therapyInhibition of duck hepatitis B virus replication by 9-(2-phosphonylmethoxyethyl)adenine, an acyclic phosphonate nucleoside analogueSubunit specificity of mutations that confer resistance to nonnucleoside inhibitors in human immunodeficiency virus type 1 reverse transcriptase.Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain.Comparative fitness of multi-dideoxynucleoside-resistant human immunodeficiency virus type 1 (HIV-1) in an In vitro competitive HIV-1 replication assayDifferential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells.Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors.Influence of prior exposure to zidovudine on stavudine phosphorylation in vivo and ex vivoSynthesis and anti-HIV activity of 2'-deoxy-2'-fluoro-4'-C-ethynyl nucleoside analogs.Predicting virus mutations through statistical relational learning.Antiviral activities of isometric dideoxynucleosides of D- and L-related stereochemistry.Comparative pharmacokinetics, distributions in tissue, and interactions with blood proteins of conventional and sterically stabilized liposomes containing 2',3'-dideoxyinosineDidanosine reduces atevirdine absorption in subjects with human immunodeficiency virus infectionsSelection and characterization of a mutant of feline immunodeficiency virus resistant to 2',3'-dideoxycytidineMutants of feline immunodeficiency virus resistant to 2',3'-dideoxy-2',3'-didehydrothymidine.Identification of a novel type of small molecule inhibitor against HIV-1.Antiviral therapy for human immunodeficiency virus infectionsIn search of a selective antiviral chemotherapy.Structural modifications of nucleosides in ionic liquidsA novel Met-to-Thr mutation in the YMDD motif of reverse transcriptase from feline immunodeficiency virus confers resistance to oxathiolane nucleosidesThe Continuing Evolution of HIV-1 Therapy: Identification and Development of Novel Antiretroviral Agents Targeting Viral and Cellular Targets.Rapid phenotypic reversion of zidovudine-resistant feline immunodeficiency virus without loss of drug-resistant reverse transcriptasePoliovirus RNA-dependent RNA polymerase (3Dpol): pre-steady-state kinetic analysis of ribonucleotide incorporation in the presence of Mg2+.AIDS: The final chapter?Variation of human immunodeficiency virus type-1 reverse transcriptase within the simian immunodeficiency virus genome of RT-SHIV.Enhanced binding of azidothymidine-resistant human immunodeficiency virus 1 reverse transcriptase to the 3'-azido-3'-deoxythymidine 5'-monophosphate-terminated primer.
P2860
Q28302073-34203866-3E7A-41DD-9377-B7C0B602B5AAQ28343672-E8E80260-2962-4512-8427-83D4E21F4910Q28368003-0C3691FE-29EE-4382-9D9E-5DE8AADC8CF5Q28368016-7206B46D-377C-4FBB-B4E2-4FF5491AED0AQ28368032-2A22FF8C-8435-418F-B874-12B9AE65CC6EQ28369082-450F970B-34F5-4DED-B54C-66EC1C8CE2A0Q28369309-3D49CB82-FE63-45FB-8F6F-FC8DD4499D9AQ28378905-0222AC5A-42CC-41CD-A625-EF48651E64D0Q28379011-B306A510-1A93-4A50-89A0-94377AFC5D94Q28379411-D55EBF3B-7BD8-43FF-952B-E12A5ADC448BQ28379471-F80D3D15-6EEB-49A4-9644-1276605ABC2BQ30658869-B1933E26-3EDC-477B-A8A7-4D2639EF48B1Q31938029-94F4523F-5CF1-41F3-97F1-F0526A3F7EC0Q33228536-84CF39DC-3F0F-44F6-BAA5-189C23EB0562Q33486144-7AABEB0F-49B5-422F-A95A-68040370E390Q33702993-88519177-8CC9-42E5-BA12-F1D0EA588D4BQ33757596-07228924-A3F2-4B6B-8686-46085C4894FBQ33804495-39F2F3E8-C39B-4E9E-A288-5131C1660976Q33814927-797FDC05-896D-4878-91D6-78AAB31E733DQ33900606-A1A5CB2C-5C56-40AD-A04D-472B651D17B1Q33957283-02E33A83-ACBC-435F-A545-D9DEB044AEEAQ33981459-650744AE-0C75-41C8-B302-34778C22A6FCQ34041566-84D6041E-2A91-43A1-83B3-8273263619E2Q34669126-EC8A9DD2-893A-457F-93C5-EBDE4DB94AB0Q35114114-23AAE422-B24E-4B8D-A8A8-F147AD241409Q35122037-CBB0D553-9777-4143-AB1D-69F98801BFE4Q35123292-F8885880-4DF2-4B3F-A263-79838D8A19E1Q35123759-976C9939-23B5-403D-9647-A9448AEC1A60Q35126454-B2B9D0C2-08C6-4900-90D4-04A584C815A6Q35156489-90450AA9-3510-4100-9514-1B6173F6A306Q35366050-EF7AD406-568C-4D12-993D-4EB9290806ABQ35375912-DD37C842-7E3D-4482-A9CB-D83C3CD3DEB1Q35545547-CFEE9D9A-7441-4264-A8C3-3A195C4C8BE8Q35879410-8D4B5E57-F54A-49A0-84BD-CCCFFA7CEB5BQ36104509-96108E0A-7E80-4C7E-822B-D41438EE750EQ36626377-44FD22B8-8304-40EE-A816-3C097D1ED5F4Q36718302-9A425A15-585F-4A6F-B6B3-2672FEEA12F6Q37460188-7D0CF1FC-0D4D-4418-AAE8-821147841597Q37538534-50CADA5A-FDFD-443C-98C9-B4AA74D17AB2Q38336814-E9642B99-03D4-4022-9008-F130A907C19A
P2860
description
1992 nî lūn-bûn
@nan
1992 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
HIV inhibitors targeted at the reverse transcriptase.
@ast
HIV inhibitors targeted at the reverse transcriptase.
@en
type
label
HIV inhibitors targeted at the reverse transcriptase.
@ast
HIV inhibitors targeted at the reverse transcriptase.
@en
prefLabel
HIV inhibitors targeted at the reverse transcriptase.
@ast
HIV inhibitors targeted at the reverse transcriptase.
@en
P356
P1476
HIV inhibitors targeted at the reverse transcriptase.
@en
P2093
De Clercq E
P304
P356
10.1089/AID.1992.8.119
P577
1992-02-01T00:00:00Z